0001419051 false 0001419051 2023-07-07 2023-07-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 07, 2023

 

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Nevada   000-54554   45-1226465

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

701 Wild Rose Lane
Elk City, Idaho 83525
(Address of Principal Executive Offices and Zip Code)
 
(760) 295-7208
(Issuer’s telephone number)
 
 
(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   .
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   .
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   .
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

 

Item 1.01 Entry into a Material Definitive Agreement

 

On July 5, 2023, Therapeutic Solutions International, Inc., and CTE Biologics, Inc., entered into an exclusive patent license agreement, included here in exhibit 10.1.

 

Item 8.01 Other Events.

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference including reference to exhibits.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit Index

 

(10.1) Exclusive Patent License Agreement between Therapeutic Solutions International, Inc. and CTE Biologics, Inc.

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 7, 2023  
     
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.  
     
By: /s/ Timothy Dixon   
Timothy Dixon   
Chief Executive Officer   

 

 

  

 

Exhibit 10.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
v3.23.2
Cover
Jul. 07, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 07, 2023
Entity File Number 000-54554
Entity Registrant Name THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Entity Central Index Key 0001419051
Entity Tax Identification Number 45-1226465
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 701 Wild Rose Lane
Entity Address, City or Town Elk City
Entity Address, State or Province ID
Entity Address, Postal Zip Code 83525
City Area Code 760
Local Phone Number 295-7208
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false

Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Jan 2024 to Feb 2024 Click Here for more Therapeutic Solutions (PK) Charts.
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Feb 2023 to Feb 2024 Click Here for more Therapeutic Solutions (PK) Charts.